deltatrials
Completed NA INTERVENTIONAL 2-arm NCT02473042

Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV)

Intraoperative Electrical Stimulation of the Acupoint P6 to Prevent Post-Operative Nausea and Vomiting in Women Undergoing Breast Cancer Surgery

Sponsor: M.D. Anderson Cancer Center

Conditions Breast Cancer Post-Operative Nausea and Vomiting
Interventions Dexamethasone Electrical Stimulation Pepcid Phenergan Questionnaire Zofran
Updated 18 times since 2017 Last updated: Dec 3, 2025 Started: Mar 1, 2016 Primary completion: Nov 26, 2024 Completion: Nov 26, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Breast Cancer and Post-Operative Nausea and Vomiting, this trial is completed. The trial is conducted by M.D. Anderson Cancer Center and has accumulated 18 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Oct 2017 · 8 months · monthly snapshot~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshot~Jun 2018 – ~Apr 2019 · 10 months · monthly snapshot~Apr 2019 – ~Jun 2019 · 2 months · monthly snapshot~Jun 2019 – ~Sep 2020 · 15 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Jul 2022 · 7 months · monthly snapshot~Jul 2022 – ~May 2023 · 10 months · monthly snapshot~May 2023 – ~Nov 2023 · 6 months · monthly snapshot~Nov 2023 – ~May 2024 · 6 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~Jan 2025 · 2 months · monthly snapshot~Jan 2025 – ~Jan 2026 · 12 months · monthly snapshot~Jan 2026 – present · 6 months · monthly snapshot

Change History

18 versions recorded

  1. Jan 2026 — Present [monthly]

    Completed NA

  2. Jan 2025 — Jan 2026 [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed

  3. Nov 2024 — Jan 2025 [monthly]

    Active Not Recruiting NA

  4. Sep 2024 — Nov 2024 [monthly]

    Active Not Recruiting NA

  5. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

▶ Show 13 earlier versions

  1. May 2024 — Jul 2024 [monthly]

    Active Not Recruiting NA

  2. Nov 2023 — May 2024 [monthly]

    Active Not Recruiting NA

  3. May 2023 — Nov 2023 [monthly]

    Active Not Recruiting NA

  4. Jul 2022 — May 2023 [monthly]

    Active Not Recruiting NA

  5. Dec 2021 — Jul 2022 [monthly]

    Active Not Recruiting NA

  6. Jan 2021 — Dec 2021 [monthly]

    Active Not Recruiting NA

  7. Sep 2020 — Jan 2021 [monthly]

    Active Not Recruiting NA

  8. Jun 2019 — Sep 2020 [monthly]

    Active Not Recruiting NA

  9. Apr 2019 — Jun 2019 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  10. Jun 2018 — Apr 2019 [monthly]

    Recruiting NA

  11. Oct 2017 — Jun 2018 [monthly]

    Recruiting NA

  12. Feb 2017 — Oct 2017 [monthly]

    Recruiting NA

  13. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • M.D. Anderson Cancer Center
Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations